COVID-19

Artificial intelligence has the potential to expand the role of chest imaging in COVID-19 beyond diagnosis, enabling new insights at the molecular, health-care system, and population scales. The COVID-19 response can be scaled up with the help of health technology. Dr. Shinjini Kundu described some of these applications in this Radiology: Artificial Intelligence editorial. She was also an agenda contributor to the World Economic Forum in 2020.

Shinjini Kundu
Physician and Computer Scientist

My research interests include machine learning, medical imaging, and the human brain.

Publications

Artificial intelligence (AI) has the potential to expand the role of chest imaging in COVID-19 beyond diagnosis to enable risk stratification, treatment monitoring, and discovery of novel therapeutic targets. AI’s power to generate models from large volumes of information—fusing molecular, clinical, epidemiologic, and imaging data—may accelerate solutions to detect, contain, and treat COVID-19.